Department of Urology and Pediatric Urology, Saarland University, Kirrberger Street 100, 66421, Homburg/Saar, Germany.
Medical Department III: Renal and Hypertensive Diseases, Immunology and Dialysis, SHG Kliniken Völklingen, Richardstraße 5-9, 66333, Völklingen, Germany.
World J Urol. 2024 Feb 16;42(1):85. doi: 10.1007/s00345-024-04779-8.
The Eurotransplant Senior program allocating grafts from donors ≥ 65 years to recipients aged ≥ 65 years has proven good results within the last 20 years. However, "old" grafts are also allocated to younger recipients < 65 years, and this outcome of "old for young" kidney transplantations (KT) still lacks detailed investigations.
All "old for young" KT performed at four tertiary referral centers were retrospectively compared including a recent follow-up, stratifying for "old for young" (donor ≥ 65 years to recipient < 65 years) vs. "very old for young" KT (donor ≥ 70 years to recipient < 65 years).
Overall, 99 patients were included with 56 (56.6%) "old for young" and 43 (43.4%) "very old for young" KT. The median waiting time did not differ (60.7 vs. 45.8 months, respectively) at comparable living donation rates (57.1% vs. 44.2%) as well as intra- and postoperative results. At a median follow-up of 44 months (range 1; 133), the 3-year graft survival of 91% vs. 87% did not significantly vary. In subgroup analyses assessing living donation or donation after brain death (DBD) KT only, the graft survival was significantly longer for "old for young" KT within the living donation subgroup. In multivariate Cox regression analyses, the presence of panel-reactive antibodies was the only significant impact factor on graft survival (HR 8.32, p = 0.001).
This analysis clearly demonstrates the effectiveness of the "old for young" approach, enabling favorable perioperative results as well as comparable data of graft- and overall survival, while reducing waiting time for eligible patients.
在过去的 20 年中,Eurotransplant Senior 项目将供体年龄≥65 岁的移植物分配给受体年龄≥65 岁的患者,已取得良好效果。然而,“老年”移植物也被分配给年龄<65 岁的年轻受者,而这种“老对少”的肾脏移植(KT)的结果仍缺乏详细的调查。
回顾性比较了四家三级转诊中心进行的所有“老对少”KT,包括近期随访,并按“老对少”(供体年龄≥65 岁,受体年龄<65 岁)与“非常老对少”KT(供体年龄≥70 岁,受体年龄<65 岁)进行分层。
共纳入 99 例患者,其中 56 例(56.6%)为“老对少”KT,43 例(43.4%)为“非常老对少”KT。在相似的活体捐献率(57.1%对 44.2%)以及围手术期结果下,等待时间中位数无差异(分别为 60.7 个月和 45.8 个月)。在中位随访 44 个月(范围 1-133)时,3 年移植物存活率分别为 91%和 87%,差异无统计学意义。在仅评估活体捐献或脑死亡供体(DBD)KT 的亚组分析中,在活体捐献亚组中,“老对少”KT 的移植物存活率显著更长。在多变量 Cox 回归分析中,面板反应性抗体的存在是影响移植物存活率的唯一显著因素(HR 8.32,p=0.001)。
本分析清楚地表明了“老对少”方法的有效性,能够实现围手术期的良好结果,以及移植物和总体存活率的可比数据,同时减少了符合条件的患者的等待时间。